EGFRvIII peptide PEPvIII |
| رقم الكتالوجGC35967 |
ببتيد EGFRvIII PEPvIII هو طفرة خاصة بالورم يتم التعبير عنها على نطاق واسع في الورم الأرومي الدبقي متعدد الأشكال (GBM) والأورام الأخرى ويعزز تعبيرها تكوين الأورام. يمثل الببتيد EGFRvIII هدفًا خاصًا بالورم حقًا للعلاج المناعي المضاد للورم.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 129112-17-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
EGFRvIII peptide (PEPvIII) is a tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms and its expression enhances tumorigenicity. EGFRvIII peptide represents a truly tumor-specific target for antitumor immunotherapy[1].
[1]. Schmittling RJ, et al. Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines. J Immunol Methods. 2008 Nov 30;339(1):74-81.
Average Rating: 5 (Based on Reviews and 40 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *